Pilar
Marcos Perez
Hospital Universitari de Bellvitge
l'Hospitalet de Llobregat, EspañaPublicacións en colaboración con investigadores/as de Hospital Universitari de Bellvitge (8)
2023
-
Key Factors Associated With Pulmonary Sequelae in the Follow-Up of Critically Ill COVID-19 Patients
Archivos de Bronconeumologia, Vol. 59, Núm. 4, pp. 205-215
2022
-
Major candidate variables to guide personalised treatment with steroids in critically ill patients with COVID-19: CIBERESUCICOVID study
Intensive Care Medicine, Vol. 48, Núm. 7, pp. 850-864
2021
-
Correction to: The evolution of the ventilatory ratio is a prognostic factor in mechanically ventilated COVID-19 ARDS patients (Critical Care, (2021), 25, 1, (331), 10.1186/s13054-021-03727-x)
Critical Care
-
The evolution of the ventilatory ratio is a prognostic factor in mechanically ventilated COVID-19 ARDS patients
Critical Care, Vol. 25, Núm. 1
2016
-
Consumption of systemic antifungal agents among acute care hospitals in Catalonia (Spain), 2008-2013
Expert Review of Anti-Infective Therapy, Vol. 14, Núm. 1, pp. 137-144
2012
-
Comparison of quality of life after stereotactic body radiotherapy and surgery for early-stage prostate cancer
Radiation Oncology, Vol. 7, Núm. 1
-
Impact of non-neurological complications in severe traumatic brain injury outcome
Critical Care, Vol. 16, Núm. 2
2008
-
Health-Related Quality of Life 2 Years After Treatment With Radical Prostatectomy, Prostate Brachytherapy, or External Beam Radiotherapy in Patients With Clinically Localized Prostate Cancer
International Journal of Radiation Oncology Biology Physics, Vol. 72, Núm. 2, pp. 421-432